VICR.NASDAQVicor CORP

Form 4: Vicor Corp Director Andrew D'Amico Executes Stock Options and Sells Shares Under 10b5-1 Plan

Sentiment:

SEC Form 4 Filing


Director Andrew D'Amico exercised stock options and sold shares of Vicor Corp common stock on February 21, 2025, under a pre-arranged Rule 10b5-1 trading plan.

Summary

  • On February 21, 2025, Andrew D'Amico, a director of Vicor Corp, executed non-qualified stock options to acquire 1,000 shares at $16.15 and 800 shares at $16.6.
  • Simultaneously, D'Amico sold 1,000 shares of common stock at $62 and 800 shares at $64.
  • These transactions were conducted under a Rule 10b5-1 trading plan adopted on September 12, 2024.
  • Following these transactions, D'Amico directly owns zero shares of Vicor Corp common stock.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions by a company director. It doesn't inherently convey positive or negative sentiment.

Industry Context

This filing is a routine disclosure of insider trading activity. It is common for executives to use 10b5-1 plans to diversify their holdings and avoid accusations of trading on inside information.

Stakeholder Impact

  • The transactions may have a minor impact on shareholders due to the change in ownership.

Key Dates

DateDescription
2024-09-12Date of adoption of Rule 10b5-1 trading plan
2025-02-21Date of stock option exercise and stock sale
2025-02-25Date of Form 4 filing
2027-03-02Expiration date of Non Qualified Stock Option for 1,000 shares
2027-03-20Expiration date of Non Qualified Stock Option for 800 shares

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.